First Data Presentations for CAR T Programs, Including DLL3 in Small Cell Lung Cancer and FLT3 in Acute Myeloid Leukemia
Pre-Clinical Data Evaluating Half-Life Extended Anti-BCMA BiTE® Presented for First-Time
New Data Include two Studies Investigating Mcl-1 Inhibitor AMG 176
PR Newswire
THOUSAND OAKS, Calif., April 9, 2018